- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
A public complaint about clinical trial disclosure for Lyxumia was ruled outwith the scope of the ABPI Code…
A GP complained that a Cipralex cost bar chart implied generic competitor prices but actually used branded prices.…
A complaint about a Novartis tweet relating to liver disease. The PMCPA concluded no breach because the matter…
Anonymous ex-employee alleged an online trade-journal interview promoted unlicensed medicines to the public. Panel found PME targeted pharma…
Sanofi’s Dupixent website hosted a NICE guidance resource with Oct 2017 prescribing information and an HCP guide stating…
Ex-employee alleged Allergan product specialists promoted Botox via Instagram tags/hashtags linking to HCP/clinic posts. Panel found breaches, but…
LEO made a voluntary admission after five 2020 transfers of value (4 HCP, 1 HCO) were omitted from…
Ex-employee alleged CSL Vifor’s non-promotional NHS service was targeted to Ferinject-using hospitals and amounted to disguised promotion/inducement. Panel…
Five weight-loss media articles were complained about. Novo Nordisk was not responsible for four. One Sunday Times interview…
An events business employee posted a public X photo where “Invokana canagliflozin tablets” was legible on Menarini’s stand.…
One real case. One key lesson. Every week — free.